HARBOR CAPITAL ADVISORS, INC. TCR2 Therapeutics Inc. Transaction History

HARBOR CAPITAL ADVISORS, INC. portfolio value:

$125,000
portfolio value

HARBOR CAPITAL ADVISORS, INC. quarter portfolio value change:

-37.93%
quarter

TCR2 Therapeutics Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +8.30% 5.34K shares -62K $1.8 69.68K
Q2 2022 share Decrease -4.77% -3.22K shares 1K $2.9 64.34K
Q1 2022 share Decrease -19.20% -16.05K shares -204K $2.76 67.56K
Q4 2021 share Increase 0.00% 83.61K shares 390K $4.79 83.61K